Clinical Trials Browser

Phase 1 × Peripheral Nervous System Diseases × 90 days × Clear all

NCT06405542 2026-06-04

EX-CIPN

Phase 1 Active not recruiting

Peripheral Nervous System Diseases

NCT07484022 2026-06-03

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

Phase 1 Recruiting

Carcinoma, Transitional Cell, Peripheral Nervous System Diseases